Lineage Cell Therapeutics, Inc. - COM (LCTX)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM
Number of holders
99
Total Shares
65.1M
Shares change
+496K
Total reported value, excl. options
$76.1M
Value change
+$592K
Put/Call ratio
0.09
Number of buys
46
Number of sells
-30
Price
$1.17
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.